Six Texas-based orthopedic group practices have announced the 2021 launch of OrthoLoneStar, a single combined group practice.
OrthoLoneStar is physician owned and comprised of six divisions from across Texas. It includes Dallas-based W.B. Carrell Clinic and Texas Orthopaedic Associates, Houston-based Fondren Orthopedic Group and Advanced Orthopaedics & Sports Medicine, Austin-based Texas Orthopedics, Sports & Rehabilitation Associates, and Tyler-based Azalea Orthopedics.
The divisions have long-standing foundations in their communities. In 2021, W.B. Carrell Clinic will celebrate its 100-year anniversary. According to the press release, this makes it the oldest orthopedic practice west of the Mississippi.
Robert R. Scheinberg, M.D., an OrthoLoneStar executive committee member from Texas Orthopaedic Associates discussed the merger with OTW: “These specific groups are joining together because we share the ability to truly make a difference for patients and in healthcare.”
Dr. Scheinberg continued, “Our ability to deliver quality care, to understand patient needs, and to improve the private practice environment is accelerated through sharing resources, best practices, and clinical excellence. Our mission is to reach all Texans, and our combination provides an excellent platform to begin doing that.”
OrthoLoneStar will have over 40 practice centers across Texas, providing a full range of orthopedic care. It will have more than 150 physicians and 1,000 employees. While this group is large, it plans to continue to expand. The press release indicates that future strategic plans are to add additional providers and locations across Texas.
The founding divisions believe that a physician led practice delivers the best value to the patient. OrthoLoneStar Medical Director J. Bryan Williamson, M.D. commented, “There is no better pathway to bring quality healthcare directly to patients than through their independent physician. By bringing together groups with proven quality, we are able to dedicate best-in-class resources to drive value to the patient.”